Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit
Lucid Diagnostics (Nasdaq: LUCD), a commercial-stage cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The event will feature a fireside chat with Dennis McGrath, Lucid's Chief Financial Officer, scheduled for Tuesday, October 15, 2024, at 11:30 AM Eastern Time.
Interested parties can attend the virtual fireside chat by visiting the provided link. Following the conference, a recording of the session will be available on Lucid's investor relations website. This participation demonstrates Lucid's commitment to engaging with investors and sharing insights about their cancer prevention diagnostics business.
Lucid Diagnostics (Nasdaq: LUCD), una società di diagnostica medica per la prevenzione del cancro in fase commerciale e filiale di PAVmed Inc. (Nasdaq: PAVM), ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. L'evento prevede una conversazione informale con Dennis McGrath, il Chief Financial Officer di Lucid, prevista per martedì 15 ottobre 2024, alle 11:30 ora orientale.
Le parti interessate possono partecipare alla chat virtuale seguendo il link fornito. Dopo la conferenza, una registrazione della sessione sarà disponibile sul sito web delle relazioni con gli investitori di Lucid. Questa partecipazione dimostra l'impegno di Lucid a interagire con gli investitori e condividere approfondimenti sul loro business di diagnostica per la prevenzione del cancro.
Lucid Diagnostics (Nasdaq: LUCD), una empresa de diagnósticos médicos comerciales para la prevención del cáncer y subsidiaria de PAVmed Inc. (Nasdaq: PAVM), ha anunciado su participación en el 2024 Maxim Healthcare Virtual Summit. El evento contará con una charla al calor de la lumbre con Dennis McGrath, el Director Financiero de Lucid, programada para el martes 15 de octubre de 2024, a las 11:30 AM, hora del Este.
Las partes interesadas pueden asistir a la charla virtual siguiendo el enlace proporcionado. Después de la conferencia, se dispondrá de una grabación de la sesión en el sitio web de relaciones con los inversores de Lucid. Esta participación demuestra el compromiso de Lucid por interactuar con los inversores y compartir ideas sobre su negocio de diagnósticos para la prevención del cáncer.
Lucid Diagnostics (Nasdaq: LUCD)는 상업 단계의 암 예방 의료 진단 회사이자 PAVmed Inc.의 자회사(Nasdaq: PAVM)로서 2024 Maxim Healthcare Virtual Summit에 참여한다고 발표했습니다. 이 행사에서는 Dennis McGrath Lucid의 최고 재무 책임자와의 대화가 2024년 10월 15일 화요일 동부 표준시 기준 오전 11시 30분에 예정되어 있습니다.
관심 있는 분들은 제공된 링크를 통해 가상 대화에 참석하실 수 있습니다. 회의 후에는 Lucid의 투자자 관계 웹사이트에서 세션의 녹화본을 볼 수 있습니다. 이 참여는 Lucid가 투자자와 소통하고 암 예방 진단 사업에 대한 통찰을 공유하겠다는 의지를 보여줍니다.
Lucid Diagnostics (Nasdaq: LUCD), une entreprise de diagnostics médicaux en phase commerciale spécialisée dans la prévention du cancer et filiale de PAVmed Inc. (Nasdaq: PAVM), a annoncé sa participation au 2024 Maxim Healthcare Virtual Summit. L'événement comprendra une discussion informelle avec Dennis McGrath, directeur financier de Lucid, prévue pour le mardi 15 octobre 2024, à 11h30, heure de l'Est.
Les parties intéressées peuvent assister à la discussion virtuelle en suivant le lien fourni. Après la conférence, un enregistrement de la session sera disponible sur le site Web des relations avec les investisseurs de Lucid. Cette participation démontre l'engagement de Lucid à dialoguer avec les investisseurs et à partager des informations sur leur activité de diagnostics pour la prévention du cancer.
Lucid Diagnostics (Nasdaq: LUCD), ein Unternehmen für medizinische Diagnostik zur Krebsprävention in der kommerziellen Phase und Tochtergesellschaft von PAVmed Inc. (Nasdaq: PAVM), hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit bekannt gegeben. Bei der Veranstaltung wird ein informelles Gespräch mit Dennis McGrath, dem Chief Financial Officer von Lucid, stattfinden, das für Dienstag, den 15. Oktober 2024, um 11:30 Uhr Eastern Time geplant ist.
Interessierte können an dem virtuellen Gespräch teilnehmen, indem sie dem bereitgestellten Link folgen. Nach der Konferenz wird eine Aufnahme der Sitzung auf der Website der Investor Relations von Lucid verfügbar sein. Diese Teilnahme zeigt Lucids Engagement für den Dialog mit Investoren und den Austausch von Erkenntnissen über ihr Geschäft mit Diagnosen zur Krebsprävention.
- None.
- None.
Event Details:
- Date: Tuesday, October 15, 2024
- Time: 11:30 AM Eastern Time
- Format: Fireside Chat with Dennis McGrath, Lucid's Chief Financial Officer
- Venue: Virtual
For more information about the 2024 Maxim Healthcare Virtual Summit and to attend Lucid's fireside chat, please visit https://m-vest.com/events/healthcare-10152024.
A recording of the fireside chat will be made available on the investor relations section of the Company's website at ir.luciddx.com following the conclusion of the conference.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.
For more information about Lucid, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-participate-in-the-2024-maxim-healthcare-virtual-summit-302271379.html
SOURCE Lucid Diagnostics
FAQ
When is Lucid Diagnostics (LUCD) participating in the 2024 Maxim Healthcare Virtual Summit?
Who will represent Lucid Diagnostics (LUCD) at the 2024 Maxim Healthcare Virtual Summit?
How can investors attend Lucid Diagnostics' (LUCD) fireside chat at the 2024 Maxim Healthcare Virtual Summit?
Will there be a recording available of Lucid Diagnostics' (LUCD) presentation at the 2024 Maxim Healthcare Virtual Summit?
